{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:54:50Z","timestamp":1786996490556,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["DP2-HL163810"],"award-info":[{"award-number":["DP2-HL163810"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["I-2121-20220331"],"award-info":[{"award-number":["I-2121-20220331"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["847236"],"award-info":[{"award-number":["847236"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007914","name":"University of Texas Southwestern Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Structural Biology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.sbi.2023.102700","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T14:09:46Z","timestamp":1694786986000},"page":"102700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Conformational inhibitors of protein aggregation"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3265-5242","authenticated-orcid":false,"given":"Mar\u00eda del Carmen","family":"Fern\u00e1ndez Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumaila","family":"Afrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1904-2150","authenticated-orcid":false,"given":"Lorena","family":"Saelices","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sbi.2023.102700_bib1","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1042\/bj0292351","article-title":"The X-ray interpretation of denaturation and the structure of the seed globulins","volume":"29","author":"Astbury","year":"1935","journal-title":"Biochem J"},{"key":"10.1016\/j.sbi.2023.102700_bib2","first-page":"213","article-title":"Amyloid nomenclature 2022: update, novel proteins, and recommendations by the international society of amyloidosis (ISA) nomenclature committee","volume":"29","author":"Buxbaum","year":"2022","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"10.1016\/j.sbi.2023.102700_bib3","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3389\/fphar.2020.01024","article-title":"Treating protein misfolding diseases: therapeutic successes against systemic amyloidoses","volume":"11","author":"Nevone","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.sbi.2023.102700_bib4","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sbi.2023.102700_bib5","first-page":"24","article-title":"Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma","volume":"28","author":"Nelson","year":"2021","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"10.1016\/j.sbi.2023.102700_bib6","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1073\/pnas.1817567116","article-title":"Stabilization of amyloidogenic immunoglobulin light chains by small molecules","volume":"116","author":"Morgan","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sbi.2023.102700_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127356","article-title":"Structural basis for the stabilization of amyloidogenic immunoglobulin light chains by hydantoins","volume":"30","author":"Yan","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.sbi.2023.102700_sref8","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1021\/acschemneuro.2c00116","article-title":"A\u00a0small molecule stabilizes the disordered native state of the Alzheimer's A\u03b2 peptide","volume":"13","author":"L\u00f6hr","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.sbi.2023.102700_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb5924","article-title":"Small-molecule sequestration of amyloid-\u03b2 as a drug discovery strategy for Alzheimer's disease","volume":"6","author":"Heller","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.sbi.2023.102700_bib10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.chembiol.2008.09.011","article-title":"Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules","volume":"15","author":"Follis","year":"2008","journal-title":"Chem Biol"},{"key":"10.1016\/j.sbi.2023.102700_bib11","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/anie.200802123","article-title":"Cognitive-performance recovery of Alzheimer's disease model mice by modulation of early soluble amyloidal assemblies","volume":"48","author":"Frydman-Marom","year":"2009","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.sbi.2023.102700_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuropharm.2014.12.038","article-title":"MRZ-99030 - a novel modulator of A\u03b2 aggregation: I - mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)","volume":"92","author":"Parsons","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.sbi.2023.102700_bib13","doi-asserted-by":"crossref","first-page":"20954","DOI":"10.1038\/s41598-020-77712-9","article-title":"The retinal toxicity profile towards assemblies of Amyloid-\u03b2 indicate the predominant pathophysiological activity of oligomeric species","volume":"10","author":"Naaman","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.sbi.2023.102700_bib14","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sbi.2023.102700_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002361","article-title":"Molecular basis of Orb2 amyloidogenesis and blockade of memory consolidation","volume":"14","author":"Herv\u00e1s","year":"2016","journal-title":"PLoS Biol"},{"key":"10.1016\/j.sbi.2023.102700_sref16","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-022-32951-4","article-title":"Structure-based discovery of small molecules that disaggregate Alzheimer's disease tissue derived tau fibrils in\u00a0vitro","volume":"13","author":"Seidler","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.sbi.2023.102700_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12937-016-0179-4","article-title":"Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)","volume":"15","author":"Singh","year":"2016","journal-title":"Nutr J"},{"key":"10.1016\/j.sbi.2023.102700_bib18","article-title":"The aggregation inhibitor peptide\u00a0QBP1 as a therapeutic molecule for the polyglutamine neurodegenerative diseases","volume":"2011","author":"Popiel","year":"2011","journal-title":"J\u00a0Amino Acids"},{"key":"10.1016\/j.sbi.2023.102700_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001335","article-title":"Common features at the start of the neurodegeneration cascade","volume":"10","author":"Herv\u00e1s","year":"2012","journal-title":"PLoS Biol"},{"key":"10.1016\/j.sbi.2023.102700_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108113","article-title":"Molecular\u00a0mechanism of the inhibition of TDP-43 amyloidogenesis by QBP1","volume":"675","author":"Mompe\u00e1n","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.sbi.2023.102700_sref21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12915-021-00967-9","article-title":"Divergent CPEB prion-like domains reveal different assembly mechanisms for a generic amyloid-like fold","volume":"19","author":"Herv\u00e1s","year":"2021","journal-title":"BMC Biol"},{"key":"10.1016\/j.sbi.2023.102700_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202209252","article-title":"Expanded conformations of monomeric tau initiate its amyloidogenesis","volume":"62","author":"Fern\u00e1ndez-Ram\u00edrez","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.sbi.2023.102700_bib23","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.1074\/jbc.RA120.013440","article-title":"The inhibition of cellular toxicity of amyloid-\u03b2 by dissociated transthyretin","volume":"295","author":"Cao","year":"2020","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.sbi.2023.102700_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16565-1","article-title":"The A\u03b2 oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology","volume":"7","author":"van Groen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.sbi.2023.102700_bib25","doi-asserted-by":"crossref","first-page":"100630","DOI":"10.1016\/j.xcrm.2022.100630","article-title":"A\u03b2 oligomer concentration in mouse and human brain and its drug-induced reduction ex\u00a0vivo","volume":"3","author":"Kass","year":"2022","journal-title":"Cell reports Med"},{"key":"10.1016\/j.sbi.2023.102700_bib26","article-title":"Safety and pharmacokinetics of the orally available antiprionic compound PRI-002: a single and multiple ascending dose phase I study","volume":"6","author":"Kutzsche","year":"2020","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.sbi.2023.102700_bib27","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature03680","article-title":"Structure of the cross-beta spine\u00a0of\u00a0amyloid-like fibrils","volume":"435","author":"Nelson","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2023.102700_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nchem.2889","article-title":"Structure-based\u00a0inhibitors\u00a0of tau aggregation","volume":"10","author":"Seidler","year":"2018","journal-title":"Nat Chem"},{"key":"10.1016\/j.sbi.2023.102700_bib29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnmol.2019.00054","article-title":"Structure-based peptide inhibitor design of amyloid-\u03b2 aggregation","volume":"12","author":"Lu","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.sbi.2023.102700_bib30","doi-asserted-by":"crossref","first-page":"28932","DOI":"10.1074\/jbc.M115.659912","article-title":"Uncovering the mechanism of aggregation of human transthyretin","volume":"290","author":"Saelices","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.sbi.2023.102700_bib31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41594-020-0435-3","article-title":"Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils","volume":"27","author":"Cao","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.sbi.2023.102700_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ccell.2015.12.002","article-title":"A\u00a0designed inhibitor of p53 aggregation rescues p53 tumor suppression in ovarian carcinomas","volume":"29","author":"Soragni","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.sbi.2023.102700_sref33","article-title":"Design of amyloidogenic peptide traps","author":"Sahtoe","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.sbi.2023.102700_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.xphs.2019.10.024","article-title":"Passive immunotherapies targeting amyloid beta and tau oligomers in Alzheimer's disease","volume":"109","author":"Vander Zanden","year":"2020","journal-title":"J\u00a0Pharmaceut Sci"},{"key":"10.1016\/j.sbi.2023.102700_bib35","series-title":"Aducanumab","author":"Padda","year":"2023"},{"key":"10.1016\/j.sbi.2023.102700_bib36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1471-4159.2007.04759.x","article-title":"Sensitive ELISA detection of amyloid-beta protofibrils in biological samples","volume":"103","author":"Englund","year":"2007","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.sbi.2023.102700_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2009.08.007","article-title":"An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease","volume":"36","author":"Lord","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.sbi.2023.102700_bib38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3233\/JAD-140741","article-title":"The murine version of BAN2401 (mAb158) selectively reduces amyloid-\u03b2 protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice","volume":"43","author":"Tucker","year":"2015","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.sbi.2023.102700_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sbi.2023.102700_sref40","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1038\/s41467-021-23274-x","article-title":"A\u00a0human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells","volume":"12","author":"Michalon","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.sbi.2023.102700_bib41","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2303765","article-title":"Phase 1 trial of antibody NI006 for depletion of cardiac transthyretin amyloid","author":"Garcia-Pavia","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sbi.2023.102700_bib42","article-title":"Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses","volume":"6","author":"Galant","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.sbi.2023.102700_bib43","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacbts.2019.02.002","article-title":"Emerging therapeutics for the treatment of light chain and transthyretin amyloidosis","volume":"4","author":"Zhang","year":"2019","journal-title":"JACC Basic to Transl Sci"},{"key":"10.1016\/j.sbi.2023.102700_bib44","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood.2020009039","article-title":"Phase 1a\/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis","volume":"138","author":"Edwards","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.sbi.2023.102700_bib45","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000507724","article-title":"Nonchemotherapy treatment of immunoglobulin light chain amyloidosis","volume":"143","author":"Van Doren","year":"2020","journal-title":"Acta Haematol"},{"key":"10.1016\/j.sbi.2023.102700_bib46","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood-2021-146076","article-title":"Birtamimab in patients with mayo stage IV AL amyloidosis: rationale for confirmatory affirm-AL phase 3 study design","volume":"138","author":"Gertz","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.sbi.2023.102700_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.870517","article-title":"Impact of anti-amyloid-\u03b2 monoclonal antibodies on the pathology and clinical profile of Alzheimer's disease: a focus on Aducanumab and Lecanemab","volume":"14","author":"Shi","year":"2022","journal-title":"Front Aging Neurosci"}],"container-title":["Current Opinion in Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959440X23001744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959440X23001744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:26:27Z","timestamp":1760707587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959440X23001744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":47,"alternative-id":["S0959440X23001744"],"URL":"https:\/\/doi.org\/10.1016\/j.sbi.2023.102700","relation":{},"ISSN":["0959-440X"],"issn-type":[{"value":"0959-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conformational inhibitors of protein aggregation","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Structural Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sbi.2023.102700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102700"}}